Magnetar Financial’s Integra LifeSciences IART Stock Holding History

Magnetar Financial’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,313	Closed	-$224K	–	562
2024 Q1	$224K	Sell	6,313 -7,102	-53%	-$284K	0.01%	339
2023 Q4	$584K	Buy	+13,415	New	+$528K	0.01%	297
2022 Q4	–	Sell	-58,746	Closed	-$2.49M	–	853
2022 Q3	$2.49M	Buy	+58,746	New	+$3.01M	0.03%	526
2021 Q3	–	Sell	-3,102	Closed	-$212	–	1404
2021 Q2	$212	Buy	+3,102	New	+$219K	﹤0.01%	1096
2020 Q3	–	Sell	-11,659	Closed	-$548K	–	686
2020 Q2	$548K	Buy	+11,659	New	+$573K	0.02%	260
2017 Q4	–	Sell	-10,655	Closed	-$538K	–	790
2017 Q3	$538K	Buy	+10,655	New	+$547K	0.01%	411
2017 Q2	–	Sell	-24,788	Closed	-$1.04M	–	869
2017 Q1	$1.04M	Buy	+24,788	New	+$1.06M	0.01%	292
2016 Q4	–	Sell	-12,952	Closed	-$535K	–	192
2016 Q3	$535K	Buy	12,952 +3,564	+38%	+$149K	0.01%	353
2016 Q2	$374K	Buy	+9,388	New	+$338K	0.01%	263
2015 Q3	–	Sell	-8,731	Closed	-$240K	–	456
2015 Q2	$240K	Buy	+8,731	New	+$233K	﹤0.01%	399

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Magnetar Financial's IART Position: Q2 2024 in Review

Magnetar Financial sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 6,313 shares — an estimated $224K sold.

Magnetar Financial first reported a position in IART in Q2 2015 and held it in 10 quarters. The position peaked at $2.49M in Q3 2022. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

Magnetar Financial reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
Magnetar Financial sold 6,313 Integra LifeSciences shares in Q2 2024, an estimated $224K.
Magnetar Financial first reported a position in Integra LifeSciences in Q2 2015 and held it in 10 quarters.
Magnetar Financial's Integra LifeSciences position peaked at $2.49M in Q3 2022.
238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Magnetar Financial's 13F filing for Q2 2024, filed 14 Aug 2024.